期刊文献+

自拟补肾活血汤治疗帕金森病30例临床观察 被引量:6

下载PDF
导出
摘要 目的:探讨自拟补肾活血汤治疗帕金森病的临床疗效。方法:将60例帕金森病患者随机分为治疗组与对照组各30例。对照组患者给予美多巴进行治疗。治疗组在对照组的基础上加用自拟补肾活血汤治疗。两组均治疗3个月后进行综合疗效评价。结果:两组帕金森病评定量表(UPDRS)各项积分进行比较,差异有统计学意义(P<0.05),治疗组优于对照组;总有效率治疗组为90%,对照组为60%,治疗组均优于对照组,差异有统计学意义(P<0.05)。结论:补肾活血汤结合美多巴对帕金森病患者运动功能有明显的改善作用。
作者 安畅
出处 《中医药导报》 2013年第6期41-43,共3页 Guiding Journal of Traditional Chinese Medicine and Pharmacy
  • 相关文献

参考文献5

  • 1Daliri MR. Chi -square distance kernel of the gaits forthe diagnosis of Parkinson's disease [J]. Biomed SignalProcess Control, 2013,8(1):66-70.
  • 2中医老年颤证诊断和疗效评定标准[J].北京中医学院学报,1992,15(4):39-41. 被引量:499
  • 3朱文锋.中医诊断学[M].北京:中国中医药出版社,2007.148.
  • 4陈生弟.帕金森病治疗指南[J].中华神经科杂志,2006,39(6):409-412. 被引量:102
  • 5Seidel SE, Tilley BC, Yuko Y PH, et al. Subject-inves-tigator reproducibility of the Unified Parkinson's DiseaseRating Scale[J]. Parkinsonism Relat Disord, 2012,18(3):230-233.

二级参考文献16

  • 1Parkinson Study Group.Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease.N Engl J Med,1993,328:176-183.
  • 2Riederer P,Lachenmayer L.Selegiline's neuroprotective capacity revisited.J Neural Transm,2003,110:1273-1278.
  • 3Shults CW,Oakes D,Kieburtz K,et al.Effects of coenzyme Q10 in early Parkinson disease:evidence of slowing of the functional decline.Arch Neurol,2002,59:1541-1550.
  • 4Albin RL,Frey KA.Initial agonist treatment of Parkinson disease.Neurology,2003,60:390-394.
  • 5Olanow W,Schapira AH,Rascol O.Continuous dopamine-receptor stimulation in early Parkinson's disease.Trends Neurosci,2000,23(10 Suppl):S117-S126.
  • 6Olanow CW,Watts RL,Koller WC.An algorithm (decision tree)for the management of Parkinson's disease (2001):treatment guidelines.Neurology,2001,56(11 Suppl 5):S1-S88.
  • 7Junghanns S,Glockler T,Reichmann H.Switching and combining of dopamine agonists.Neurol,2004,251 Suppl 6:VI/19-23.
  • 8Olanow CW,Stocchi F.COMT inhibitors in Parkinson's disease can they prevent and/or reverse levodopa-induced motor complications?Neurology,2004,62 Suppl 1:S72-S81.
  • 9Waters C.Other pharmacological treatments for motor complications and dyskinesias.Mov Disord,2005,20 Suppl Ⅱ:S38-S44.
  • 10Shiraishi M,Kamo T,Hotta M,et al.Usefulness of switching to cabergoline from other dopamine agonists in patients with advanced Parkinson's disease.J Neural Transm,2004,111:725-732.

共引文献668

同被引文献97

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部